STAT’s Adam Feuerstein has thrown a bucket of cool water on merchants in Palatin Applied sciences (PTN -6.7%) and AMAG Prescribed capsules (AMAG -5.4%) after the FDA nod for female hypoactive sexual desire disorder med Vyleesi (bremelanotide injection) on Friday. Shares were up 39% and 12%, respectively, since then earlier than retracing.
Mr. Feuerstein has been a lengthy-time frame bear on the drug, questioning its efficacy and the truth that it’s a long way an injectable in voice of a pill that could maybe also constrain question.
Subscribe for fats textual stutter news in your inbox
Leave a comment
Sign in to post your comment or sign-up if you don't have any account.